<img src="https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7?size=2" nborder="0" align="left" hspace="5" vspace="5" title="22157.jpg" alt="Company Logo"/>The NIPT market's growth opportunities lie in expanding its clinical applications, leveraging advanced sequencing technologies, and increasing adoption for low-risk pregnancies. Rising maternal age, awareness, and supportive policies drive demand, with significant potential in early-stage testing and burgeoning Asia Pacific markets.Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The <a href="https://www.researchandmarkets.com/reports/6256901/non-invasive-prenatal-testing-market-by?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=633r3d&amp;utm_campaign=2298909+-+Global+Non-Invasive+Prenatal+Testing+Market+Report+%e2%80%94+Just+Released%3b+Comprehensive+181-Page+Analysis+with+Broad+Product+and+Application+Scope&amp;utm_exec=clshmsai" rel="nofollow" target="_blank" title="Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032">"Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company Profiles, Market Dynamics, Trends and Recent Developments - Global Forecast to 2032"</a> has been added to ResearchAndMarkets.com's offering. The global non-invasive prenatal testing (NIPT) market, valued at USD 5.08 billion in 2025, is projected to surpass USD 9.85 billion by 2032. NIPT, utilizing cell-free fetal DNA (cfDNA) from maternal blood, offers a safer and more accurate screening option for fetal chromosomal disorders, including trisomies and sex chromosome aneuploidies, compared to conventional invasive procedures. NIPT can be performed at 9-10 weeks of gestation, facilitating earlier clinical decision-making. This market is driven by rising chromosomal abnormalities, increased maternal age, and growing awareness of early prenatal screening benefits. The expanding clinical applications of NIPT, technological advancements, reduced sequencing costs, and improved bioinformatics enhance its accuracy and adoption. Favorable reimbursement policies, government initiatives, and a preference for non-invasive methods also fuel market growth. Recent Developments <ul><li>Natera launched Fetal Focus in August 2025, a non-invasive test for cystic fibrosis and other inherited single-gene conditions, achieving over 90% accuracy. Supported by the EXPAND trial, it provides crucial prenatal information without invasive procedures, especially when the baby's father is unavailable for genetic testing.</li><li>In October 2024, Yourgene Health partnered with Genetix to offer Colombia's first local NIPT service, significantly reducing turnaround times and improving access to advanced prenatal genetic screening services.</li></ul> By Product: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>Consumables &amp; reagents dominated the market in 2025 due to recurring use in procedures and high diagnostic demand.</li><li>The instruments segment, supported by advanced NGS platforms and automated systems, accounted for over 25% of the market.</li></ul> By Gestation Period: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>The 13-24 weeks segment led the market due to high cfDNA concentration and test accuracy.</li><li>The 0-12 weeks segment is the fastest-growing, driven by early risk assessment demand and technological advancements.</li><li>The 25-36 weeks segment has a smaller market share, reserved for follow-up evaluations or late-term assessments.</li></ul> By Pregnancy Risk: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>High- and average-risk pregnancy segments dominated the market, supported by strong clinical adoption and guidelines.</li><li>The low-risk pregnancy segment is the fastest-growing, propelled by increasing acceptance of universal screening.</li></ul> By Technology: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>NGS technology dominated, offering high accuracy and broad genomic coverage.</li><li>Array technology is notable for targeted genetic testing of sub-chromosomal abnormalities.</li><li>PCR technology is set for rapid growth, favored for its cost-effectiveness and quick results.</li></ul> By Application: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>Trisomy detection remains the largest contributor to the market, driven by strong clinical adoption and accuracy.</li><li>The microdeletion syndrome segment is the fastest-growing application area.</li></ul> By End User: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>Diagnostic laboratories dominated in 2025, providing efficient sample processing with advanced sequencing platforms.</li><li>Hospitals &amp; clinics hold a significant share, integrating NIPT into routine prenatal care.</li></ul> By Region: Global Non-Invasive Prenatal Testing Market - Key Takeaways <ul><li>North America led the market, bolstered by advanced infrastructure and widespread adoption.</li><li>Europe follows with established screening programs and access to genetic testing.</li><li>Asia Pacific is the fastest-growing region, driven by healthcare expenditure, maternal age rise, and improved technology access.</li></ul> The report provides a comprehensive analysis of the Global Non-Invasive Prenatal Testing Market, analyzed from multiple viewpoints including product, gestation period, pregnancy risk, technology, application, end user, and region. Key Topics Covered: 1. Executive Summary 2. Research Methodology 2.1 Research Design 2.2 Research Approach 2.3 Data Collection Methods 2.4 Market Assumptions 3. Global - Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 4. Global - Non-Invasive Prenatal Testing Market Share and Forecast (2021 - 2032) 4.1 By Product - Non-Invasive Prenatal Testing Market Share and Forecast 4.2 By Gestation Period - Non-Invasive Prenatal Testing Market Share and Forecast 4.3 By Pregnancy Risk - Non-Invasive Prenatal Testing Market Share and Forecast 4.4 By Technology - Non-Invasive Prenatal Testing Market Share and Forecast 4.5 By Application - Non-Invasive Prenatal Testing Market Share and Forecast 4.6 By End User - Non-Invasive Prenatal Testing Market Share and Forecast 4.7 By Region - Non-Invasive Prenatal Testing Market Share and Forecast 5. By Product - Global Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 5.1 Global Non-Invasive Prenatal Testing - Consumables &amp; Reagents Market and Forecast 5.2 Global Non-Invasive Prenatal Testing - Instruments Market and Forecast 6. By Gestation Period - Global Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 6.1 Global Non-Invasive Prenatal Testing - (0-12) Weeks Market and Forecast 6.2 Global Non-Invasive Prenatal Testing - (13-24) Weeks Market and Forecast 6.3 Global Non-Invasive Prenatal Testing - (25-36) Weeks Market and Forecast 7. By Pregnancy Risk - Global Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 7.1 Global Non-Invasive Prenatal Testing - High &amp; Average Risk Market and Forecast 7.2 Global Non-Invasive Prenatal Testing - Low Risk Market and Forecast 8. By Technology - Global Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 8.1 Global Non-Invasive Prenatal Testing - NGS Market and Forecast 8.2 Global Non-Invasive Prenatal Testing - Array Technology Market and Forecast 8.3 Global Non-Invasive Prenatal Testing - PCR Market and Forecast 8.4 Global Non-Invasive Prenatal Testing - Others Market and Forecast 9. By Application - Global Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 9.1 Global Non-Invasive Prenatal Testing - Trisomy Detection Market and Forecast 9.2 Global Non-Invasive Prenatal Testing - Microdeletion Syndrome Market and Forecast 9.3 Global Non-Invasive Prenatal Testing - Others Market and Forecast 10. By End User- Global Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 10.1 Global Non-Invasive Prenatal Testing - Diagnostic Laboratories Market and Forecast 10.2 Global Non-Invasive Prenatal Testing - Hospitals &amp; Clinics Market and Forecast 11. By Region - Non-Invasive Prenatal Testing Market and Forecast (2021 - 2032) 11.1 North America - Non-Invasive Prenatal Testing Market and Forecast 11.1.1 United States - Non-Invasive Prenatal Testing Market and Forecast 11.1.2 Canada - Non-Invasive Prenatal Testing Market and Forecast 11.2 Europe - Non-Invasive Prenatal Testing Market and Forecast 11.2.1 Germany - Non-Invasive Prenatal Testing Market and Forecast 11.2.2 United Kingdom - Non-Invasive Prenatal Testing Market and Forecast 11.2.3 France - Non-Invasive Prenatal Testing Market and Forecast 11.2.4 Italy - Non-Invasive Prenatal Testing Market and Forecast 11.2.5 Spain - Non-Invasive Prenatal Testing Market and Forecast 11.2.6 Netherlands - Non-Invasive Prenatal Testing Market and Forecast 11.3 Asia Pacific - Non-Invasive Prenatal Testing Market and Forecast 11.3.1 Japan - Non-Invasive Prenatal Testing Market and Forecast 11.3.2 China - Non-Invasive Prenatal Testing Market and Forecast 11.3.3 India - Non-Invasive Prenatal Testing Market and Forecast 11.3.4 Australia - Non-Invasive Prenatal Testing Market and Forecast 11.3.5 South Korea - Non-Invasive Prenatal Testing Market and Forecast 11.4 Latin America - Non-Invasive Prenatal Testing Market and Forecast 11.4.1 Brazil - Non-Invasive Prenatal Testing Market and Forecast 11.4.2 Mexico - Non-Invasive Prenatal Testing Market and Forecast 11.4.3 Argentina - Non-Invasive Prenatal Testing Market and Forecast 11.5 Middle East &amp; Africa - Non-Invasive Prenatal Testing Market and Forecast 11.5.1 South Africa - Non-Invasive Prenatal Testing Market and Forecast 11.5.2 Saudi Arabia - Non-Invasive Prenatal Testing Market and Forecast 11.5.3 UAE - Non-Invasive Prenatal Testing Market and Forecast 12. Global Non-Invasive Prenatal Testing Market - Key Trends 13. Global Non-Invasive Prenatal Testing Market - Recent Developments 14. Global Non-Invasive Prenatal Testing Market - Key Company Profiles 14.1 BillionToOne, Inc. 14.2 Revvity, Inc. 14.3 Illumina, Inc. 14.4 Natera, Inc. 14.5 Qiagen N.V. 14.6 Labcorp Holdings Inc. 14.7 Eurofins Scientific SE 14.8 Apollo Hospitals Enterprise Limited 14.9 BGI Genomics Co., Ltd. 14.10 IHH Healthcare Berhad 15. Global Non-Invasive Prenatal Testing - Market Dynamics 15.1 Global Non-Invasive Prenatal Testing Market - Drivers 15.2 Global Non-Invasive Prenatal Testing Market - Challenges Companies Featured <ul><li>BillionToOne, Inc.</li><li>Revvity, Inc.</li><li>Illumina, Inc.</li><li>Natera, Inc.</li><li>Qiagen N.V.</li><li>Labcorp Holdings Inc.</li><li>Eurofins Scientific SE</li><li>Apollo Hospitals Enterprise Limited</li><li>BGI Genomics Co., Ltd.</li><li>IHH Healthcare Berhad</li></ul> For more information about this report visit <a href="https://www.researchandmarkets.com/reports/6256901/non-invasive-prenatal-testing-market-by?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=633r3d&amp;utm_campaign=2298909+-+Global+Non-Invasive+Prenatal+Testing+Market+Report+%e2%80%94+Just+Released%3b+Comprehensive+181-Page+Analysis+with+Broad+Product+and+Application+Scope&amp;utm_exec=clshmsai" rel="nofollow" target="_blank" title="">https://www.researchandmarkets.com/r/okpqf9</a> About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. <pre>CONTACT: 
CONTACT: ResearchAndMarkets.com 
 Laura Wood,Senior Press Manager 
 press@researchandmarkets.com
 For E.S.T Office Hours Call 1-917-300-0470 
 For U.S./ CAN Toll Free Call 1-800-526-8630 
 For GMT Office Hours Call +353-1-416-8900 

</pre> <img alt="" src='https://ml.globenewswire.com/media/M2RkMmIwMWEtZDdlMy00YWE2LTgzYjMtZTgwZTE4NDJhMDJmLTEwMjY3MzctMjAyNi0wNy0xMy1lbg==/tiny/Research-and-Markets.png' referrerpolicy='no-referrer-when-downgrade' />

GlobeNewswire Inc.

Global Non-Invasive Prenatal Testing Market Report — Just Released; Comprehensive 181-Page Analysis with Broad Product and Application Scope

Latest news from the world of business and finance – both local and global

MONEY FM 89.3 is Singapore's first and only Business and Personal Finance station, featuring local and international business and financial news.

MONEY FM 89.3

Discover newsletters from our DJs on LinkedIn